Faes Farma SA (FAE.MC) stock: key figures, P/E, revenue and dividend

Health Care · Spain · ISIN ES0134950F36

Price
4.74 EUR
Market cap
1.48 bn EUR
P/E (2025)
18.53
P/S (2025)
2.43
Dividend yield
2.70 %
Net margin
12.95 %
Return on equity (ROE)
10.61 %
Return on assets (ROA)
5.89 %

Faes Farma SA financials

Fiscal year20242025
Revenue493.00 m EUR610.00 m EUR
Gross profit326.00 m EUR228.00 m EUR
Operating income108.53 m EUR88.82 m EUR
EBIT107.00 m EUR76.00 m EUR
Net income111.00 m EUR79.00 m EUR
Diluted EPS – continuing operations0.36 EUR0.26 EUR

Full history since 1996, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Faes Farma SA

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.